Aethlon Medical Inc. (AEMD)
AEMD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2024-03-31, https://www.sec.gov/Archives/edgar/data/882291/000168316824004530/0001683168-24-004530-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2024-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | AEMD on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000882291 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2023
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$12.2M |
| Operating income | -$12.6M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | -100.0% |
| Cash | $5.4M |
| Total assets | $8.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. "Based on its assessment, management concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the date these financial statements are issued." | 10-Q 2026-11-12 |
| Cash and burn | $6.5M cash; operating cash flow -$1.8M a quarter. | Report 2026-09-30 |
| Shares outstanding | 1,607,367 (2026-11-12); 761,318 a year earlier; 2,492,908 three years earlier. 1y figure adjusted for splits (1-for-5 overall); 3y figure adjusted for splits (1-for-400 overall). | Cover page 2026-11-12 |
| Reverse splits, 3 years | 3; latest 1-for-5 on 2026-08-04 | Source 2026-08-04 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-06-04 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Haskell & White LLP, Irvine, California, United States | PCAOB Form AP 2026-06-10 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-09-30 | Not filed | -$2.6M | -$1.7M | $6.5M | No debt tags | Needs four quarters | 10-Q 2026-11-12 |
| Q1 2027 2026-06-30 | Not filed | -$1.5M | -$1.9M | $4.9M | No debt tags | Needs four quarters | 10-Q 2026-11-12 |
| Q4 2026 2026-03-31 | Not filed | -$1.9M | -$1.8M | $5.0M | No debt tags | Needs four quarters | 10-K 2026-06-10 |
| Q3 2026 2025-12-31 | Not filed | -$2.0M | -$1.9M | $7.0M | No debt tags | Needs four quarters | 10-Q 2026-02-12 |
| Q2 2026 2025-09-30 | Not filed | -$1.5M | -$1.7M | $5.9M | No debt tags | Needs four quarters | 10-Q 2026-11-12 |
| Q1 2026 2025-06-30 | Not filed | -$1.8M | -$1.7M | $3.8M | No debt tags | Needs four quarters | 10-Q 2026-11-12 |
| Q4 2025 2025-03-31 | Not filed | -$6.3M | -$1.7M | $5.5M | No debt tags | Needs four quarters | 10-K 2026-06-10 |
| Q3 2025 2024-12-31 | Not filed | -$1.8M | -$2.0M | $4.8M | No debt tags | Needs four quarters | 10-Q 2026-02-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-07-07 |
| Latest annual report FORM 10-K FOR MAR 2026 | 10-K | 2026-06-10 |
| Latest quarterly / interim FORM 10-Q FOR SEP 2026 | 10-Q | 2026-11-12 |
| Latest current report CURRENT REPORT | 8-K | 2026-11-16 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-09-04 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.3% |
| 1 month | -5.2% |
| 3 months | +80.5% |
| Year to date | -61.8% |
| 1 year | -77.7% |
| From 52-week high | -78.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ARAY | Accuray Incorporated | $2.55 | -8.93% | $7.7M |
| PLSM | Pulsenmore Ltd. | $1.41 | +2.17% | $9.2M |
| CNSY | Cerenome Inc. Common Stock | $0.7148 | -24.77% | $7.0M |
| NMTC | NeuroOne Medical Technologies Corporation | $0.7450 | -0.01% | $6.8M |
| SINT | SiNtx Technologies Inc. | $1.34 | -1.11% | $10.1M |
| FEMY | Femasys Inc. | $1.28 | -8.57% | $11.1M |
| WOK | WORK Medical Technology Group LTD | $1.23 | +2.50% | $5.5M |
| DRIO | DarioHealth Corp. | $1.15 | -8.73% | $13.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier